Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × Hydrocortisone × Clear all

Prostatic Neoplasms

NCT06104449 2026-03-06

MK-5684-005

Phase 1 Active not recruiting

6 enrolled

Genitourinary

Prostatic Neoplasms

NCT06136598 2026-02-17

MK-5684-001

Phase 1 Active not recruiting

14 enrolled

Genitourinary

Prostatic Neoplasms

NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Available

BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

NCT00181597 2013-12-03

Trilostane for Androgen-Independent Prostate Cancer

Phase 2 Completed

24 enrolled

Genitourinary

Prostatic Neoplasms

NCT00705822 2010-11-30

PROSTATA

Phase 3 Terminated

54 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

MK-5684-004

MK-5684-005

MK-5684-001

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Trilostane for Androgen-Independent Prostate Cancer

PROSTATA